(Q37587159)

21 August 2017

1 reference

title

Agomelatine: innovative pharmacological approach in depression (English)

1 reference

21 August 2017

1 reference

Maurizio Popoli

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

23 Suppl 2

1 reference

21 August 2017

page(s)

27-34

1 reference

Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11318640-000000000-00000

Melatonin or a melatonin agonist corrects age-related changes in circadian response to environmental stimulus

21 January 2018

1 reference

12 December 2020

Severe depression: is there a best approach?

1 reference

12 December 2020

Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system

1 reference

12 December 2020

Antidepressant-like effects of agomelatine (S 20098) in the learned helplessness model.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

12 December 2020

Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group

1 reference

12 December 2020

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

1 reference

12 December 2020

Circadian rhythm mechanisms in affective illness and in antidepressant drug action

1 reference

12 December 2020

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).

1 reference

12 December 2020

The psychological aspects of patients with delayed sleep phase syndrome (DSPS)

1 reference

12 December 2020

New approaches to antidepressant drug discovery: beyond monoamines

1 reference

12 December 2020

Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial

1 reference

12 December 2020

Entrainment of circadian rhythms by S-20098, a melatonin agonist, is dose and plasma concentration dependent

1 reference

12 December 2020

Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment

1 reference

12 December 2020

Agomelatine: a preliminary review of a new antidepressant

1 reference

12 December 2020

Sleep research in depressive illness: clinical implications--a tasting menu

1 reference

12 December 2020

Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group

1 reference

12 December 2020

Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus.

1 reference

12 December 2020

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

1 reference

12 December 2020

A melatonin agonist facilitates circadian resynchronization in old hamsters after abrupt shifts in the light-dark cycle

1 reference

12 December 2020

Cost of depression in Europe

1 reference

12 December 2020

Biological rhythm disturbances in mood disorders

1 reference

12 December 2020

Entrainment of rat circadian rhythms by the melatonin agonist S-20098 requires intact suprachiasmatic nuclei but not the pineal

1 reference

12 December 2020

The interaction between the internal clock and antidepressant efficacy.

1 reference

12 December 2020

Effect of agomelatine in the chronic mild stress model of depression in the rat.

1 reference

12 December 2020

Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial

1 reference

12 December 2020

Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities

1 reference

12 December 2020

Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality

1 reference

12 December 2020

Synaptic effects of antidepressants

1 reference

12 December 2020

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

1 reference

12 December 2020

New selective ligands of human cloned melatonin MT1 and MT2 receptors.

1 reference

12 December 2020

Circadian rhythm of mt1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse

1 reference

12 December 2020

Daytime sleepiness and insomnia as correlates of depression.

1 reference

12 December 2020

DEPRES II (Depression Research in European Society II): a patient survey of the symptoms, disability and current management of depression in the community. DEPRES Steering Committee

1 reference

12 December 2020

Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance.

1 reference

12 December 2020

Organization and function of a central nervous system circadian oscillator: the suprachiasmatic hypothalamic nucleus

1 reference

12 December 2020

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

1 reference

12 December 2020

10.2165/11318640-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1048198006

0 references

1 reference